Last reviewed · How we verify
HTU-520 Patch
At a glance
| Generic name | HTU-520 Patch |
|---|---|
| Also known as | HTU-520 |
| Sponsor | Hisamitsu Pharmaceutical Co., Inc. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety & Efficacy Study of HTU-520 in the Treatment of Distal Subungual Onychomycosis of the Toenail (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HTU-520 Patch CI brief — competitive landscape report
- HTU-520 Patch updates RSS · CI watch RSS
- Hisamitsu Pharmaceutical Co., Inc. portfolio CI